CAVHANZA
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
70709-192 -
Package NDC
70709-192-12 -
Application number
NDA217379 -
SPL ID
5bfb2610-4fa7-4f4c-bfba-7bed50e63ef3 -
SPL set ID
98b197ea-bca4-427e-8737-97f70a3262bc -
UNII
F41401512X -
RxCUI
2747509 -
RxCUI
2747516 -
RxCUI
2747518 -
RxCUI
2747520
What the source publishes
- Labeler
- Cycle Pharmaceuticals Ltd
- Active ingredients
- Nilotinib
- Form
- TABLET, ORALLY DISINTEGRATING
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- NDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "CAVHANZA",
"splId": "5bfb2610-4fa7-4f4c-bfba-7bed50e63ef3",
"labels": [
{
"setId": "98b197ea-bca4-427e-8737-97f70a3262bc",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=98b197ea-bca4-427e-8737-97f70a3262bc",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=98b197ea-bca4-427e-8737-97f70a3262bc"
}
],
"routes": [
"ORAL"
],
"labeler": "Cycle Pharmaceuticals Ltd",
"finished": true,
"packaging": [
{
"sample": false,
"description": "112 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (70709-192-12)",
"package_ndc": "70709-192-12",
"identifierStatus": "well-formed",
"marketing_start_date": "20260630"
}
],
"productId": "70709-192_5bfb2610-4fa7-4f4c-bfba-7bed50e63ef3",
"useDomain": "unknown",
"dosageForm": "TABLET, ORALLY DISINTEGRATING",
"productNdc": "70709-192",
"deaSchedule": null,
"genericName": "Nilotinib",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "NILOTINIB",
"strength": "80 mg/1"
}
],
"applicationNumber": "NDA217379",
"marketingCategory": "NDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20260630",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175605",
"N0000020009",
"N0000187062",
"N0000182137",
"N0000187064",
"N0000187063",
"N0000191272",
"N0000185503"
],
"upc": [
"0370709191126"
],
"unii": [
"F41401512X"
],
"rxcui": [
"2747509",
"2747516",
"2747518",
"2747520"
],
"spl_set_id": [
"98b197ea-bca4-427e-8737-97f70a3262bc"
],
"pharm_class_epc": [
"Kinase Inhibitor [EPC]"
],
"pharm_class_moa": [
"Bcr-Abl Tyrosine Kinase Inhibitors [MoA]",
"Cytochrome P450 2C8 Inhibitors [MoA]",
"Cytochrome P450 2D6 Inhibitors [MoA]",
"Cytochrome P450 2B6 Inducers [MoA]",
"Cytochrome P450 2C8 Inducers [MoA]",
"UGT1A1 Inhibitors [MoA]",
"P-Glycoprotein Inhibitors [MoA]"
],
"manufacturer_name": [
"Cycle Pharmaceuticals Ltd"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:70709-192_5bfb2610-4fa7-4f4c-bfba-7bed50e63ef3"